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Objective: The number of diagnosed fatal encephalitis cases in humans caused by the classical Borna disease virus
(BoDV-1) has been increasing, ever since it was proved that BoDV-1 can cause human infections. However, awareness
of this entity is low, and a specific imaging pattern has not yet been identified. We therefore provide the first compre-
hensive description of the morphology of human BoDV-1 encephalitis, with histopathological verification of imaging
abnormalities.
Methods: In an institutional review board-approved multicenter study, we carried out a retrospective analysis of
55 magnetic resonance imaging (MRI) examinations of 19 patients with confirmed BoDV-1 encephalitis. Fifty brain
regions were analyzed systematically (T1w, T2w, T2*w, T1w + Gd, and DWI), in order to discern a specific pattern of
inflammation. Histopathological analysis of 25 locations in one patient served as correlation for MRI abnormalities.
Results: Baseline imaging, acquired at a mean of 11  10 days after symptom onset, in addition to follow-up scans of
16 patients, revealed characteristic T2 hyperintensities with a predilection for the head of the caudate nucleus, insula,
and cortical spread to the limbic system, whereas the occipital lobes and cerebellar hemispheres were unaffected. This
gradient was confirmed by histology. Nine patients (47.4%) developed T1 hyperintensities of the basal ganglia,
corresponding to accumulated lipid phagocytes on histology and typical for late-stage necrosis.
Interpretation: BoDV-1 encephalitis shows a distinct pattern of inflammation in both the early and late stages of the
disease. Its appearance can mimic sporadic Creutzfeldt–Jakob disease on MRI and should be considered a differential
diagnosis in the case of atypical clinical presentation.
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Introduction
Recently, it has been demonstrated that the classical Borna
disease virus (BoDV-1; species Mammalian 1 orthobornavirus)
can lead to encephalitis in humans that is usually fatal.1–4
Consequently, the numbers of both retrospectively detected
and recent cases are increasing.5 To date, a lack of awareness
of the disease and its clinical spectrum delay correct diagnosis
and impede adequate therapy.
In animals, including horses and sheep, in which
BoDV-1 infection has been known for centuries, typical
neurological manifestations and distribution patterns have
broadly been described.6,7 For the most part, behavioral
changes, including leg crossing and scratching, are
observed. In the late stage, paralysis, blindness, and coma
resulting in death occur in most cases.6 Typically, the
olfactory bulbs and hippocampus are affected, explaining
why the olfactory system is believed to be a possible entry
point in animals.7
In humans, the disease often starts with unspecific
flu-like symptoms, followed by a broad variety of neuro-
logical symptoms, including gait ataxia, dysphagia, blurred
speech, epileptic seizures, and hemiparesis.5 A systematic
neuropathological analysis of autopsy material of 6 patients
with confirmed BoDV-1 encephalitis provided the first
hints that the distribution pattern might differ from what
we know in animals. An accentuation of the basal nuclei
was described for two deceased patients.1 Analysis of
autopsy material is, however, limited by the fact that only
the end stage of the disease can be evaluated. Life-
prolonging therapies might have influenced these findings,
especially regarding the distribution pattern. In contrast,
magnetic resonance imaging (MRI) offers the chance to
follow the course of the disease to gain a better under-
standing of the starting point and spread of the inflamma-
tion. From this point of view, discerning a specific pattern
on MRI could accelerate the identification of affected
patients and thus facilitate differentiation from other rap-
idly deteriorating conditions, such as similar encephalitis
pathogens or prion-related disease.
Patients and Methods
Data Acquisition and Virus Detection
Ii this study, we evaluated 55 brain MRI examinations from
19 patients with confirmed postmortem diagnosis of human
BoDV-1 encephalitis and included data from 4 university
hospitals, one general hospital, and two community hospitals
in southern Germany. No spinal imaging was available for
review. For all patients, the presence of BoDV-1 RNA had
been confirmed by reverse transcriptase quantitative polymer-
ase chain reaction (RT-qPCR), as described earlier.3 Addition-
ally, in 13 patients, the diagnosis of BoDV-1 encephalitis was
corroborated by immunohistochemistry against the nucleo-
protein of BoDV-1 and BoDV-1 RNA in situ hybridization
of brain tissue samples, as described previously.1 Removal of
patient-linked metadata and defacing of the MRI images for
anonymization took place before evaluation of scans.
Although data on Patient 4 (P3 of Liesche and colleagues1),
Patient 7 (P2 of Liesche and colleagues1; P6 of Coras and col-
leagues2), Patient 8 (P1 of Liesche and colleagues1; Recipient
2 of Schlottau and colleagues3), Patient 9 (P5 of Liesche and
colleagues1]), Patient 16 (P4 of Liesche and colleagues1; P7
Coras and colleagues2), Patient 11 (Recipient 1 of Schlottau
and colleagues3), Patient 14 (P2 Coras and colleagues2),
Patient 15 (P6 of Liesche and colleagues1; P8 Coras and col-
leagues2), and Patient 17 (P3 Coras and colleagues2) have
been reported previously, the focus in the preceding studies
was set on clinical information and not imaging findings.
The local ethic committees of the respective institutions
approved this retrospective study (577/19 S-SR and 560/19
S-KH).
Systematic Scan Evaluation
The magnetic resonance (MR) images were analyzed retro-
spectively, independently and in random order, by two
neuroradiologists (T.F and I.W., with MRI experience of
3 and 7 years, respectively) blinded for the scanning time
point or any clinical data beyond the fact that diagnosis of
BoDV-1 encephalitis had been confirmed. A standardized
scheme was defined to investigate 50 previously defined
brain regions (a list of evaluated regions is given in supple-
mentary Table S1) deemed anatomically and functionally
relevant. After binary determination of whether a brain
region showed any abnormalities, the intraparenchymal
location of an anomaly into cortical, subcortical, deep
white matter, or the basal ganglia was defined. Next, the
morphology and quality of a particular lesion were classi-
fied based on its delineation, mass effect, and signal alter-
ations on T1w/T2w/T2*w, lack/presence of diffusion
restriction, lack/presence of contrast enhancement, or any
combination of these signal changes. Raters were also
asked to determine whether changes were suggestive of
laminar necrosis, as defined by native T1 hyperintensity of
the cortical band.8 In divergent primary ratings, a consen-
sus rating was reached by involving a third neuroradiolo-
gist (M.P.) with 10 years of experience.
Histopathology, Immunohistochemistry, and
RNA In Situ Hybridization
From a representative patient for whom the formalin-fixed
whole-brain specimen was available (bilateral if applicable
and not specified otherwise), tissue samples from 25 loca-
tions (head of the caudate nucleus, striatum, globus
pallidus, insula, thalamus [right], hippocampus [left],
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occipital cortex, frontal cortex [right], parietal cortex [left],
cerebellar vermis, cerebellar hemisphere, deep white matter
[occipital], temporal pole [right], mesencephalon, and
leptomeninx) were retrieved for histopathological evalua-
tion. After paraffin embedding, 2μm-thick sections were
sliced and stained with Hematoxylin and Eosin (H&E).
For immunohistochemistry, an established avidin–
biotin complex technique was performed. Pretreatment in
pH 6.0 citrate buffer at 95C for 30 minutes for epitope
uncovering and H2O2 were followed by overnight incuba-
tion with the primary antibodies against GFAP (Dako
Denmark A/S, Glostrup, Denmark; polyclonal, rabbit,
dilution 1:500), Iba1 (abcam, Berlin, Germany; poly-
clonal, rabbit, dilution 1:500), CD45 (DCS Innovative
Diagnostik-Systeme, Habmurg, Germany; monoclonal,
mouse, clones 2B11 and PD7/26, dilution 1:250) and
CD68 (Dako Denmark A/S, Glostrup, Denmark; monoclo-
nal, mouse, clone KP1, dilution 1:1,500).
For evaluation of virus distribution, a monoclonal
antibody against the nucleoprotein of BoDV-1 was used,
as described previously.1 Afterwards, biotinylated second-
ary antibodies were applied for 30 minutes, followed by
incubation with avidin-biotin-complex and dia-
minobenzidine reagents. Finally, counterstaining with
Hematoxylin was conducted. Additionally, BoDV-1 RNA
in situ hybridization with the probe V-BoDV1-G
targeting 2-969 of NC_001607-1:2236-3747 (RNAscope;
Advanced Cell Diagnostics, Newark, CA) was performed
on a selection of 11 locations (bilateral if applicable and
not specified otherwise; head of the caudate nucleus, stria-
tum [right], insula, thalamus, hippocampus, parietal cor-
tex [right], occipital cortex [left], frontal cortex [left],
cerebellar vermis, cerebellar tonsils, and mesencephalon)
as described previously.9 Positive controls served as quality
assurance for all immunohistochemical stains and the
RNA in situ hybridization.
Histopathological Evaluation
Histopathological evaluation was performed by a highly
experienced neuropathologist (F.L.-S.). The density of
pathognomic Joest–Degen bodies10 was determined by
counting the number of inclusions in 10 high-power fields
(HPFs; ocular: ×10/23; objective: ×40/0.75). The severity
of edema was evaluated semiquantitatively by establishing a
score ranging from 0 (no edema) via 1 (mild) and 2 (moder-
ate) to 3 (severe edema). The virus distribution was evalu-
ated by counting BoDV-1+ cells in immunohistochemistry,
extrapolating to a standardized tissue size of 1cm2. Further-
more, cells with positive BoDV-1 RNA signal were counted
and also standardized to a tissue size of 1cm2.
For the evaluation of reactive astrogliosis and acti-
vated microglial cells, the average of GFAP+ (GFAP is
defined as glial fibrillary acidic protein) reactive astrocytes
and Iba1+ (IBA1 is defined as ionized calcium-binding
adapter molecule 1) activated microglial cells, respectively,
was calculated in 5 HPFs. All diffusely distributed CD45+
lymphocytes and CD68+ macrophages were counted and
extrapolated. Furthermore, the severity of perivascular
infiltration was determined by counting perivascularly
located CD45+ cells in 5 transversely cut vessels with simi-
lar diameter.
Twenty-five brain regions of Patient 4, who was
included in a previous study,1 were analyzed regarding the
severity of edema, astrogliosis, microglial activation, and
inflammation, in addition to detection of BoDV1 nucleopro-
tein and RNA. Given that some regions were covered by sev-
eral samples, for statistics, the results were pooled to
14 relevant areas. From the aforementioned histopathological
parameters, the general histopathology score was designed to
provide a rough comparison of the inflammatory activity
within different brain regions. For this purpose, all 14 areas
received points for their rank regarding the 5 categories, with
the highest score of 14 for the top rank and a score of 1 for
the lowest rank. The ranking scores of the 5 parameters were
summed to yield a general histopathology score.
Results
Patient and Scan Data
Complete clinical information was available for 18 of the
19 included patients (mean age 45  23 [range 11–78]
years; detailed clinical data are given in Table 1). Death
occurred in all patients with available data at a mean of
38  22 days after symptom onset. Three patients were
under immunosuppressive therapy (P8, P11, and P14),
whereas the other 16 patients had no relevant underlying
medical conditions. Fever or flu-like episodes were the
most common initial symptoms, apparent in 15 patients.
Ascending tetraparesis (P8), progressive encephalopathic
symptoms (P11), and dysarthria and visual hallucinations
(P17) were the main symptoms on admission of the
3 other patients for whom clinical information was avail-
able. All patients lived in southern Germany, a region
endemic for BoDV-1.
A total of 55 MRI scans from the 19 patients (mean
scans per patient = 3.0 [range 1–4]) were available for
analysis. All scans included a T2-weighted or fluid-
attenuated inversion recovery (FLAIR) sequence of diag-
nostic quality; 46 (84%) examinations had diffusion imag-
ing, and 46 (84%) examinations were contrast enhanced.
Fourteen patients were scanned exclusively on 1.5T
machines, 4 patients on 3T machines, and 1 patient
(P2) was scanned on a 1.5T machine for baseline and a
3T machine for follow-up imaging.
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TABLE 1. Summary of Clinical Data
Patient
Age at
Death, yr Symptoms at Admission




1 40–44 Fever, apathy, soporous state Pleocytosis (4) 26
2 10–14 Fever, reduced general state, emesis, gait
ataxia, enuresis
Pleocytosis (5) 28
3 70–74 Flu-like, with weakness of the limbs Pleocytosis (6) 12
4 10–14 Flu-like, with fever; subsequently,
altered general state, headaches,
nystagm, gait ataxia, slurred speech and
vestibular disorder
Pleocytosis, high protein, glucose and
lactate (3)
25
5 10–14 Fever, seizures, somnolence Pleocytosis, high protein and lactate,
oligoclonal bands, mildly impaired
blood–CSF barrier (24)
31
6 50–54 Fever, progressive confusion syndrome Pleocytosis, oligoclonal bands, high
protein (19)
45
7 20–24 Flu-like, with fever, headaches,
arthralgia, apathy, memory dysfunction
Pleocytosis, oligoclonal bands,
intrathecal IgM synthesis, elevated
14-3-3 protein (11)
39
8 70–74 Ascending tetraparesis, intention tremor
of the arms
Pleocytosis, impaired blood–CSF
barrier, elevated 14-3-3 protein (37)
96
9 75–79 Fever, productive cough, reduced
general state, with unsteady gait and
hemiparesis of the right side
Pleocytosis, high protein and lactate (2) 25
10 45–49 Flu-like, with headaches, disorientation Pleocytosis, impaired blood–CSF
barrier, elevated 14-3-3 protein (15)
39
11 65–69 Axonal polyneuropathy, progressive
encephalopathic syndrome (or
symptoms)
Impaired blood–CSF barrier, no
pleocytosis (5)
42
12 30–34 Flu-like, with headaches Pleocytosis, high lactate, impaired
blood–CSF barrier (4)
31
13 35–39 Fever, dizziness, nausea, vertigo Pleocytosis, high lactate, impaired
blood–CSF barrier (3)
53
14 40–44 Flu-like, with headaches and progressive
dizziness
Pleocytosis, high lactate, impaired
blood–CSF barrier (4)
67
15 55–59 Flu-like, with progressive delirium Pleocytosis, high lactate, impaired
blood–CSF barrier (12)
16
16 15–19 Flu-like, with headaches, dizziness,
ataxia, and seizures
Pleocytosis, high lactate and protein,
elevated 14-3-3 protein (9)
12
17 65–69 Reduced general state, dysarthria, visual
hallucinations
Pleocytosis, impaired blood–CSF
barrier, intrathecal IgG synthesis (7)
74
18 30–34 Flu-like, abdominal pain Pleocytosis (5) 48
19 70–75 Flu-like, confusion NA NA
In conformity with pseudonymization policies, patient age is provided only in 5-year intervals.
CSF = cerebrospinal fluid; NA = no information available; Pleocytosis refers to lymphomonocytic pleocytosis.
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Pattern and Quantitative Changes on MRI
Of the 19 included patients, 10 (53%) showed imaging
abnormalities on baseline MRI. In these scans, acquired at
a mean of 11  10 days after symptom onset, a character-
istic phenotype was distinguishable, with inflammatory
lesions mainly arising from the head of the caudate
nucleus in addition to the adjacent insula, thalamus, and
operculum in descending frequency. This distinguishable
pattern remained intact on follow-up imaging, available
for 16 patients at a mean of 26  13 days after symptom
onset, with a lesion peak in the head of the caudate
nucleus and heterogeneous spread into the adjacent paren-
chyma and brainstem now becoming more pronounced.
Notably, the regions furthest from the basal ganglia (ie, the
occipital poles and cerebellar hemispheres) were spared,
even in late-stage disease. Figure 1 shows representative
examples of this pattern.
Altogether, abnormalities were present in 41 of the
55 included scans and were distributed symmetrically
among both hemispheres in 32 (78%) scans. The lesions
showed a laterality in 7 (17%) scans and were strictly
unilateral in 2 (5%) scans.
Quantitative evaluation of all baseline scans revealed
that the count of affected brain regions per patient ranged
from 0 to 26, with a group mean of 6.1  8.5 (12.2% of
the 50 investigated anatomical areas). Cortical structures were
affected in 7 (37%) patients, the subcortical white matter in
4 (21%) patients, the deep white matter in 4 (21%) patients,
and the subcortical nuclei in 6 (32%) patients. Anatomically,
there was a strong predilection for the basal ganglia and the
limbic system, with lesions being most common in the head
of the caudate nucleus (7 [37%] patients), insula (6 [32%]
patients), and hippocampus and (posteromedially accentu-
ated) thalamus (5 [26%] patients each).
Quantitative evaluation of all follow-up scans revealed
that the number of affected brain regions per patient
increased sharply to a group mean of 19.3  13.3 (38.6% of
the 50 investigated anatomical areas) and ranged from 0 to
42 per patient. Cortical structures were affected in 12 (75%)
patients, the subcortical white matter in 4 (25%) patients,
FIGURE 1: Representative magnetic resonance imaging data of 5 patients (for clinical information, refer to Table 1) with the
typical imaging pattern for Borna disease virus (BoDV-1) encephalitis. Note the symmetrical distribution of T2-hyperintense (all
patients) and occasional diffusion-restricted (Patient 7) changes in the basal ganglia, with spread to the insular ribbon and
adjacent cortical band but sparing the occipital lobe (Patient 8) and cerebellar hemispheres (not shown). T1-hyperintense
transformation of the basal ganglia (middle row) is a characteristic finding in late-stage disease (all shown patients).
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the deep white matter in 7 (44%) patients, and the subcorti-
cal nuclei in 14 (88%) patients. By analogy to baseline scans,
the head of the caudate nucleus (13 [81%] patients) was
most commonly involved, followed by the hippocampus
(12 [75%] patients) and insular ribbon (12 [75%] patients).
For more detail, the 10 most-affected and 5 least-affected
brain regions, with their associated signal changes for the
baseline scan and follow-up scan, are presented in Table 2.
Laminar necroses were detectable in none of the
index scans and in 5 (32%) patients on follow-up. A fre-
quent phenomenon was the T1-hyperintense transforma-
tion of the basal ganglia, occurring in 9 (47%) patients at
a mean of 11  8 days before death.
Microhemorrhages, as defined by patchy T2* signal
loss, were discernable in none of the 55 systematically
evaluated scans.
Time Dependency on Imaging
The median “time-to-abnormality” on MRI was 12
(interquartile range: 5–21) days after symptom onset and
22 (interquartile range: 15–28) days before death. A pic-
togram outlining the time-dependent MRI changes is
given in Figure 2 and confirms the above-mentioned
inflammation pattern in early disease, with subsequent
spread into the adjacent parenchyma.
Correlation with Neuropathology
To confirm that the patterns described reflect the pathology
of human Borna encephalitis, we compared neuropathologi-
cal changes in 25 brain regions from Patient 4, who was
included in a previous study,1 with imaging findings in an
MR scan acquired 2 days before death (Fig 3). The MR
scan showed a typical pattern, with T2 hyperintensity of
TABLE 2. The 10 Most Frequently and 5 Least Frequently Affected Brain Regions on MRI, with their Respective
Signal Alterations for Both Baseline Scans (n = 19) and Available Follow-up Scans (n = 16)
Region




























7 (36.8%) 5 0 1 1 13 (81.3%) 8 0 1 4
Hippocampus 5 (26.3%) 1 0 1 2 12 (75.0%) 8 0 1 3
Insula 6 (31.6%) 3 0 1 2 12 (75.0%) 6 0 1 5
Parahippocampal
gyrus
5 (26.3%) 2 0 1 1 11 (68.8%) 8 0 1 2
Temporal pole 4 (21.1%) 2 0 1 1 11 (68.8%) 7 0 2 2
Thalamus 5 (26.3%) 2 0 1 2 11 (68.8%) 7 0 1 2
Frontal pole 1 (5.3%) 1 0 0 0 10 (62.5%) 7 0 1 2
Putamen 4 (21.1%) 3 0 1 0 10 (62.5%) 6 0 2 2
Gyrus rectus 2 (10.6%) 2 0 0 0 10 (62.5%) 8 0 0 2




0 (0%) 0 0 0 0 1 (6.3%) 1 0 0 0
Occipital pole 0 (0%) 0 0 0 0 1 (6.3%) 0 0 0 1
Optic nerves 0 (0%) 0 0 0 0 1 (6.3%) 1 0 0 0
Pineal gland 0 (0%) 0 0 0 0 1 (6.3%) 1 0 0 0
Cerebellar
hemisphere
1 (5.0%) 1 0 0 0 0 (0%) 0 0 0 0
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the basal ganglia, whereas the occipital lobe seemed not to
be affected. In line with this observation, histology revealed
marked changes in the basal ganglia, with strong peri-
vascular and diffusely distributed CD45+ lymphocytic infil-
trates. GFAP- and Iba1-immunohistochemistry showed
strong astroglial and microglial activation. Several cells with
a positive signal for BoDV-1 RNA could be detected. In
contrast, the occipital lobe showed only minimal inflamma-
tion. Nevertheless, it was notable that there were few
perivascular lymphocytic infiltrates and the beginning of
formation of microglial nodules.
To quantify the correlation between imaging and
neuropathology, we defined a “general histopathology
score,” as explained in the Patients and Methods section.
In this score, and by analogy to the aforementioned MRI
phenotype, a clear pattern became evident, with the
striatum and head of the caudate nucleus being most
affected, followed by the limbic regions and insula. In con-
trast, and reproducing the gradient that was distinguishable
on MRI, the cerebellar hemispheres and the occipital lobe
showed the lowest inflammation. See Table 3 for the
general histopathology score of each region.
FIGURE 2: Pictograms with a color-based inflammation pattern of selected brain regions, illustrated for the first scan (available
for 19 patients at a mean of 11  10 days after symptom onset) and the follow-up scan (available for 16 patients at a mean of
26  13 days after symptom onset). T1-hyperintense transformation of the basal ganglia was noted in 9 patients at a mean of
11  8 days before death.
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Detailed quantitative readings showed that the
highest number of Joest–Degen inclusion bodies was
observed in the left striatum (7 of 10 HPFs), followed by
the left head of the caudate nucleus and the frontal cortex
(each 6 of 10 HPFs). The lowest numbers were seen
in the cerebellar hemispheres (0 of 10 HPFs) and the
samples of the occipital lobe (average 1 of 10 HPFs).
The highest edema score was reached in the tempo-
ral pole and parietal cortex (each scoring 3). No remark-
able edema was detected in the cerebellar hemisphere
(average score 0.5).
The highest number of reactive astrocytes was found
in the thalamus (average 48.8 per HPF), followed by the
striatum (average 41.8 per HPF) and the frontal cortex
(average 40.8 per HPF). Notably, the activated astrocytes
observed were often bizarrely enlarged and of gemistocytic
and coarse appearance. The mildest astrogliosis was seen in
the deep white matter (average 21.8 per HPF), mesenceph-
alon (average 22 per HPF), and cerebellar hemispheres
(average 23.7 per HPF).
The striatum showed the highest amount of activated
microglial cells (average 199.2 per HPF), followed by the
parietal cortex (average 102 per HPF). The cerebellar hemi-
spheres (average 19.9 per HPF) and the occipital lobe (aver-
age 35 per HPF) were least affected by microglial activation.
Most diffusely distributed lymphocytes were present
in the striatum (581 lymphocytes/cm2) and the thalamus
(486/cm2). Frontal and parietal cortex showed least diffuse
inflammation (41 and 44/cm2, respectively). The strongest
perivascular infiltrate was also seen in the striatum (average
75 per vessel) and the head of the caudate nucleus (aver-
age 68 per vessel). The lowest numbers were found in the
cerebellar hemispheres (average 8 per vessel) and frontal
cortex (average 19 per vessel).
Most BoDV-1 nucleoprotein+ cells were detected in
the striatum (128/cm2) and the head of the caudate
nucleus (103/cm2), whereas the thalami and the cerebellar
hemispheres were negative for the virus protein. The
highest number of BoDV-1 RNA-positive cells was coun-
ted in the insula (158.3 positive cells/cm2) and parietal
FIGURE 3: Comparison of histopathology with magnetic resonance imaging (MRI) abnormalities. (A) MRI of Patient 4 shows T2
hyperintensity of the basal ganglia, whereas the occipital lobe seems not to be affected. (B) In line with this observation,
histology reveals marked changes in the basal ganglia, with strong perivascular (a) and diffusely distributed (d) CD45+
lymphocytic infiltrates. GFAP- and Iba1-immunohistochemistry shows strong astroglial (b) and microglial activation. Several cells
with a positive signal for Borna disease virus (BoDV-1) RNA can be detected (e). (C) In contrast, the occipital lobe shows only
minimal inflammation. Nevertheless, it is notable that there are few perivascular lymphocytic infiltrates (a) and the start of
formation of microglial nodules (c). (D, E) The histopathological correlate for the described strong T1-hyperintensity of the basal
ganglia, shown in D, is a massive accumulation of CD68+ macrophages, shown in E. (G) Note the fusiform positivity for BoDV-1
nucleoprotein (Bo18) in the cerebellar vermis, otherwise with complete negativity of the cerebellum (not shown), indicating an
incipient infiltration by the virus. Scale bars: 50μm in Ba and Be; 200μm G; 20μm in all other panels.
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cortex (145.5/cm2). No viral RNA was detected in
the occipital and frontal cortex or in the cerebellar
hemispheres.
Histopathological Correlate of T1 Hyperintensity
of the Basal Ganglia
Given that a strong T1 hyperintensity of the basal ganglia
developed in 9 patients, histopathological analysis was also
focused on outstanding changes in this area. Remarkably
massive accumulation of lipid phagocytes was observed in
the basal ganglia of Patient 4. CD68+ macrophages were
also detected in other regions, but nowhere else at such
high density, as illustrated further in Figure 3.
Discussion
Despite broad research surrounding BoDV-1 disease in
horses and sheep, attention to the potential zoonotic
spillover from the small mammal reservoir to humans
has grown only recently, owing to the rising number of
confirmed human infections in virus-endemic regions.
As far as we know, BoDV-1 disease in humans shows
strong similarities to the BoDV-1 infections in animals,
with rapidly progressive symptoms and exceedingly high
fatality rates.1–4 A recently published retrospective anal-
ysis showed that a high fraction of initially non-
classifiable fatal encephalitis cases was attributable to
BoDV-1.5 Given that clinical symptoms are often not
TABLE 3. Degree of Pathology in Different Locations: Histopathological Analyses of Patient 4 Emphasize the
Striatum and the Caput of the Caudate nucleus as Locations that are Mostly Affected in BoDV-1 Encephalitis,


















HPF (rank) cells/HPF (rank)
Score
(rank)
Striatum 59 127.8 (13) 581.4 (14) 41.8 (13) 199.2 (14) 1.5 (5)
Caput of caudate
nucleus
53 103.0 (12) 227.7 (11) 36.0 (10) 127.6 (13) 2.0 (7)
Hippocampus 47 68.5 (9) 293.9 (12) 35.2 (9) 95.2 (10) 2.0 (7)
Parietal lobe 45 82.7 (10) 44.1 (2) 34.8 (8) 102.0 (12) 3.0 (13)
Insula 40 27.1 (6) 104.3 (7) 36.5 (11) 95.0 (9) 2.0 (7)
Temporal lobe 40 9.2 (5) 55.1 (4) 32.6 (7) 97.4 (11) 3.0 (13)
Globus pallidus 39 60.9 (8) 168.5 (10) 30.5 (6) 88.5 (8) 2.0 (7)
Cerebellum,
vermis
37 150.0 (14) 150 (9) 30.0 (5) 88.2 (7) 1.0 (2)
Thalamus 34 0.0 (1) 485.7 (13) 48.8 (14) 61.8 (4) 1.0 (2)
Frontal lobe 29 5.1 (4) 40.8 (1) 40.8 (12) 67.0 (5) 2.0 (7)
Deep white
matter
25 84.6 (11) 117.3 (8) 21.8 (1) 53.4 (3) 1.0 (2)
Mesencephalon 25 33.9 (7) 52.1 (3) 22.0 (2) 74.2 (6) 2.0 (7)
Occipital lobe 10 0.9 (3) 89.5 (5) 23.8 (4) 35.0 (2) 1.5 (5)
Cerebellum,
hemispheres
12 0.0 (1) 95.9 (6) 23.7 (3) 19.9 (1) 0.5 (1)
The general histopathology score was designed by adding the ranks of all 14 investigated locations (with the highest score of 14 for the top rank and a
score of 1 for the lowest rank) regarding the 5-parameter detections of Borna disease virus (BoDV-1): nucleoprotein, diffuse lymphocytic infiltration,
astrogliosis, activated microglia, and edema. The table shows the absolute numbers (average number cells per square centimeter or per high-power field
[HPF], respectively), and the associated rank. For the evaluation of edema, the score (as described in the Patients and Methods section) is listed rather
than an absolute number.
October 2020 731
Finck et al: MRI of Bornavirus Encephalitis
discernible from other neurological diseases, early iden-
tification of affected patients through widely available
imaging would be most valuable to enable earlier
engagement in potential therapies and to facilitate delin-
eation from differential diagnoses. In this study, we pro-
vide the first comprehensive insight into the MRI
abnormalities and their histopathologic correlates for
the largest cohort so far of 19 patients with confirmed
BoDV-1 encephalitis.
In agreement with the pre-reported viral tropism in
animal models, we found a typical imaging pattern in
both the early and late stages of human BoDV-1 disease.11
As such, a distinct pattern of inflammation, with predomi-
nantly symmetric T2 hyperintensities affecting the head of
the caudate nucleus, posteromedial thalamus, insular rib-
bon, and hippocampus in the early stages of disease, was
clearly distinguishable on baseline MRI. In the later stages
of the disease, this characteristic morphology remained
intact as inflammation then spread diffusely into the adja-
cent parenchyma (especially frontal/temporal) and
brainstem. Consistent with an inflammation spread “per
continuitatem,” the lateral cerebellar hemispheres and
occipital poles, farthest away from the brain regions ini-
tially affected, remained largely unaffected until the final
stages of the disease. Accompanying diffusion restriction
of the T2-hyperintense lesions was common, as a possible
surrogate for cytotoxic edema, whereas the blood–brain
barrier was intact in most cases.
The dynamics of this pattern confirm previously pub-
lished animal studies that showed a strong tropism of
Bornaviridae for the cortical and subcortical gray matter,
with only marginal white-matter involvement.12 Although
the clear path of infection and potential zoonotic spread still
remain opaque, a theory of intranasal virus transmission
with retrograde transaxonal migration to the brain has been
proposed in horses and experimentally infected rats.7,13
Speculative causes for this olfactory susceptibility include
the direct contact of the olfactory nerves with the environ-
ment in addition to the lack of protective nerve sheathing,
with a consequently delayed immune response.14 Partly in
line with these reports, and keeping in mind that the olfac-
tory bulb per se is difficult to visualize on MRI, the gyrus
rectus that runs along the olfactory bulb showed a common
and early inflammatory involvement. Nonetheless, the alter-
ations herein seem to have spread secondarily from the
basal ganglia and not vice versa. Although highly specula-
tive, the above-mentioned pattern of encephalitis on MRI
could hence be explained more readily by an inflammation
seeding through hematogenous rather than retrograde
transaxonal spread.
Although the distribution pattern, with a predilection
for the basal ganglia, can help in the differentiation from
the more common herpes simplex virus type 1 (HSV-1) or
autoimmune encephalitis, the lack of microhemorrhages
differs from a typical late-stage finding in both HSV-1 and
Japanese encephalitis.15 The symmetric inflammation pat-
tern in Borna encephalitis can also facilitate differentiation
from HSV-1 encephalitis, in which mostly asymmetric
involvement of the temporal lobes can be seen.16
In spite of the generally biphasic and benign course
of tick-borne encephalitis, its overlapping endemic regions
and comparable flu-like initial symptoms can mimic the
characteristics of BoDV-1 encephalitis.17 MRI abnormali-
ties, which occur in only a minority of tick-borne enceph-
alitis cases, can be seen in the thalamus and basal ganglia,
but often also manifest themselves in the infratentorial
region, with typical alterations of the cerebral crus and cer-
ebellum.18,19 The frequently associated leptomeningeal
contrast enhancement and lack of parenchymal restriction
of diffusion also facilitate differentiation from BoDV-1
encephalitis19 (for comparison of BoDV-1 encephalitis
with differential diagnoses, see Table 4).
Strikingly, the preference for the head of the caudate
nucleus and striatum, with regularly associated restriction
of diffusion along the cortical band (apparent in one-
quarter of both early- and late-stage BoDV-1 encephalitis
cases), resembles the typical MRI appearance of sporadic
Creutzfeldt–Jakob disease (sCJD).20,21 Further analogies
with sCJD, such as the dramatically high lethality rates,
are, however, counterbalanced by the faster disease course,
with flu-like symptoms, in BoDV-1 encephalitis and the
fact that imaging abnormalities tend to occur much earlier
in the course of sCJD versus BoDV-1 encephalitis.20 Fur-
thermore, the occasional contrast enhancement of enceph-
alitic lesions in BoDV-1 patients is an MRI phenomenon
practically never encountered in sCJD.22 Although 14-3-3
protein could be detected in 4 of the 16 patients in whom
this test was performed, the sometimes-held conviction of
its specificity for sCJD has long been rebutted, because
this cerebrospinal fluid (CSF) marker is known to increase
in various types of conditions with severe neurological
damage, such as encephalitis.23
Rapidly occurring death in BoDV-1 encephalitis ren-
ders reliable comparison with the fulminant brain atrophy
in sCJD impossible. Nonetheless, the T1-hyperintense
transformation of the basal ganglia (an unexpected observa-
tion made in nearly half of our patients), which has also
been reported in sCJD, deserves consideration. Explanations
for this phenomenon in the basal ganglia are manifold and
concurring, but the shortened longitudinal relaxation and
subsequent increase in T1 signal can, in summary, be attrib-
uted to heightened tissue concentrations of either fat or
paramagnetic ions, such as manganese or ferrous blood
compounds. As shown by the dynamics on MRI, it seems
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TABLE 4. Head-to-Head Comparison of BoDV-1 Encephalitis with Differential Diagnoses
Entity Symptoms
1. Similar features to BoDV-1 encephalitis
on MRI
Natural course




Flu-like symptoms, fever. Gait ataxia, dysphagia,
blurred speech, hemiparesis, seizures
1. Latency of imaging abnormalities to clinical
symptoms. Characteristic appearance, with
initial predilection for the head of the caudate
nucleus, insula, striatum and limbic regions.
Subsequent spread, with typical sparing of the
occipital region and cerebellar hemispheres.
T1-hyperintense transformation of the basal
ganglia in late-stage encephalitis
Rapidly progressing, with death occurring at a
mean of 40 days
2. Not applicable
sCJD Rapid cognitive decline, ataxia, akinetic
muscular mute state23
1. T2w- and DWI abnormalities of the cerebral
cortex, usually sparing the perirolandic area.20
Involvement of the caudate nucleus and putamen,
with anterior-to-posterior gradient.21 T2w
hyperintensities of the pulvinar (vCJD)24
Fatal condition, with death occuring at a mean
of 6 mo
2. Changes may precede clinical symptoms.20
Rapidly progressing (cerebellar) atrophy.21
Involvement of the occipital cortex and generally
sparing the insula.25,26
HSV-1 Prodromal state with fever, followed by seizures,
abnormal behavior, disorientation27
1. T2w hyperintensity and diffusion restriction
in the mesiotemporal and frontal lobes15
70% mortality if untreated, neuropsychiatric
deficits common27
2. Basal ganglia tend to be spared. Mostly
asymmetric. Changes usually visible 2–3 days




From nonspecific febrile illness to poliomyelitis-
like paralysis29
1. Symmetric T2w hyperintensity, generally
without restricted diffusion (in the acute stage)
of the thalamus, basal ganglia and the brainstem.
T1-hyperintense basal ganglia, attributable to
hemorrhage. MRI can be negative ≤3 weeks
after symptom onset
Neuropsychiatric sequalae in 50%, death in
25–30% of cases29
2. T2* blooming in the later stages.30
Dengue
encephalitis
Fever, headache, retro-orbital pain. Myalgia and
arthralgia
1. Involvement of the bilateral thalami, pallidum,
temporal lobe, and hippocampus, with T2w
hyperintensity, variable diffusion restriction, and
variable contrast enhancement31
Self-limiting, with good patient recovery in most
cases




Biphasic clinical coursem with initial flu-like
symptoms17
1. T2-hyperintense lesions in the thalamus (especially
pulvinar), putamen, and crus cerebri.18,19
Mostly favorable outcome
2. Imaging abnormalities in only a minority of
cases. Affection of the cerebellum.




Fever/hypothermia, encephalopathy, acute onset
of limb weakness32
1. Predilection for deep gray matter structures
and basal ganglia. Diffusion restriction common.
Normally, no contrast enhancement33
High short-term mortality (18%), only 21%
returning to previous levels of function35,36
2. Involvement of the brainstem and cerebellum.
No findings on neuroimaging in ~30% of cases33,34
The table shows the typical respective symptoms, commonalities, and differences on MRI, in addition to the natural disease course.
BoDV-1 = classical Borna disease virus, species Mammalian 1 orthobornavirus; HSV-1 = herpes simplex virus type 1; MRI = magnetic resonance imag-
ing; sCJD = sporadic Creutzfeldt–Jakob disease; vCJD = variant Creutzfeldt–Jakob disease.
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plausible that inflammation and thus tissue damage in
BoDV-1 encephalitis is most prominent in the basal ganglia.
Taken together with histological analyses that have con-
firmed a high concentration of macrophages in these
regions, we hypothesize that late-stage necrosis leads to a
transformation of microglia into lipid phagocytes and thus
translates to this characteristic imaging appearance, a phe-
nomenon previously known to occur in hypoxic–ischemic
brain injury.24
In conclusion, this study provides the first compre-
hensive insight into the MRI morphology of BoDV-1
encephalitis. A characteristic pattern can be identified in
both the early and late stages of the disease, with inflam-
mation spreading from the head of the caudate nucleus,
striatum, insula, and limbic system into the surrounding
parenchyma. T1-hyperintense transformation of the basal
ganglia is a common finding in the days preceding death,
indicating macrophage infiltration into the most affected
necrotic zones.
Although it is pathophysiologically different, the
similar MRI features and equally devastating clinical
course render differentiation from sCJD difficult and raise
the question of whether BoDV-1 might be found retro-
spectively in prion-suspected brain samples that tested
negative for sCJD.
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